Trials / Completed
CompletedNCT01316393
Effects of Mucoprotective Product on Xerostomia
Clinical Evaluation of a Salivary Substitute and a Mucoprotective Product on Xerostomia in Head-and-neck Cancer Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Camurus AB · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
In the present study with a randomized, cross-over, blind, placebo controlled design, the effects of a salivary substitute product and a new mucoprotective product with similar mechanisms of action but with different composition and characteristics will be evaluated in cancer patients suffering from xerostomia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | XER2020 | mucoprotective product |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2011-05-01
- Completion
- 2011-06-01
- First posted
- 2011-03-16
- Last updated
- 2011-11-09
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01316393. Inclusion in this directory is not an endorsement.